Journals / Jinekoloji Obstetrik Pediatri ve Pediatrik Cerrahi Dergisi / 2012 / Cilt: 4 - Sayı: 3

The role of PAPP-A and uterine artery pulsatility index in the prediction of preecplamsia

PAPP-A ve uterin arter pulsatilite indeksi ölçümlerinin preeklampsi öngörüsündeki yeri

Pages
97–105
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The PAPP-A-related patient-specific risk for PE can be modified by the measurement of UtA-PI.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: The purpose of this study is to examine the relationship between low maternal serum pregnancy-associated plasma protein-A (PAPP-A) and uterine artery pulsatility index (UtA-PI) at 11 + 0 to 13+ 6 weeks with subsequent development of pre-eclampsia (PE) and to determine the statistical differences.
📊
Key Findings & Data:METHODS: UtA-PI and serum PAPP-A were measured in 740 women attending for routine care at 11 +0 to 13 + 6 weeks of gestation and antenatal care have been continued until delivery.RESULTS: Mean PAPP-A values were significantly lower in the PE group than the uneffected group and mean Ut-PI values were significantly higher in the PE group than the uneffected gruop CONCLUSION: Literature is controversial on this topic.
💡
Conclusion & Impact:The PAPP-A-related patient-specific risk for PE can be modified by the measurement of UtA-PI.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: The purpose of this study is to examine the relationship between low maternal serum pregnancy-associated plasma protein-A (PAPP-A) and uterine artery pulsatility index (UtA-PI) at 11 + 0 to 13+ 6 weeks with subsequent development of pre-eclampsia (PE) and to determine the statistical differences. METHODS: UtA-PI and serum PAPP-A were measured in 740 women attending for routine care at 11 +0 to 13 + 6 weeks of gestation and antenatal care have been continued until delivery.RESULTS: Mean PAPP-A values were significantly lower in the PE group than the uneffected group and mean Ut-PI values were significantly higher in the PE group than the uneffected gruop CONCLUSION: Literature is controversial on this topic. Low PAPP-A is a marker for subsequent development of PE. The PAPP-A-related patient-specific risk for PE can be modified by the measurement of UtA-PI.

Özet

AMAÇ: Çalışmanın amacı 11+0 ile 13+6 gebelik haftaların arasında ölçülen PAPP-A ve Ut-PI değerlerinin preeklampsi gelişimindeki öngörüsünü ortaya koymak ve istatistiksel olarak bir fark olup olmadığını saptamak. YÖNTEMLER: 11+0 ile 13+6 haftalarında rutin kontrol için hastanemize başvuran 740 kadının, PAPP-A ve Ut-PI değerleri ölçülerek doğuma kadar antenatal takipleri yapıldı.BULGULAR: PAPP-A ortalaması preeklampsi grubunda etkilenmemiş gruptan anlamlı olarak daha düşük olup Ut-PI ortalaması etkilenmemiş gruptan anlamlı olarak daha yüksekti.SONUÇ: Literatürde bu konudaki çalışmalar çelişkilidir. Ancak düşük PAPP-A preeklampsi gelişimi için bir belirteçtir. PAPP-A’ya bağlı hastaya özgü preeklampsi riski Ut-PI ölçümü ile desteklenebilir.

🔖

Cite This Article

YILDIRIM, G., TEKİRDAĞ, A. İ., OLGAÇ, Y., DÜNDAR, Ö. (2022). The role of PAPP-A and uterine artery pulsatility index in the prediction of preecplamsia. Jinekoloji Obstetrik Pediatri ve Pediatrik Cerrahi Dergisi, Cilt: 4 - Sayı: 3, 97–105. https://ajindex.com/articles/558556

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Papageorghio AT, Yu CHK, Bindra R, Pandis G, Nicholaides KH for fetal Medicine Foundation Second Trimester Screening Group. Multicenter screening for preeclampsia and fetal growth restriction by transvaginal uterine artery Doopler at 23 weeks of gestation. Ultrasound Obsest Gynecol 18(5):441-449
  2. Bronses IA. Morphological changes in uteroplacental bed, in pregnancy hypertension. Clin Obstet Gynaecol 1977;4:573-593. PMid:598186 3. Khong TY, Wolf F, Robertson WB, Bronses I. Inadequate maternal vascular response to placentation in pregnancies complicated by PET and small for gestational age infents. Br J Obstet Gynecol 1986;93:1049-59
  3. Kagan KO, Wright D, Valencia C, Maiz N, Nicolaides KH. Screening for trisomies 21, 18 and 13 by maternal age, fetal NT, fetal heart rate, free β hCG and PAPP-A. Human Reprod 2008; 23:1968-1975. http://dx.doi.org/10.1093/humrep/den224 PMid:18544579 5. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH. First-trimester maternal serum Free β-hCG and PAPP-A and trisomy 21. Ultrasound Obstet Gynecol 2008;31:493-502. http://dx.doi.org/10.1002/uog.5332 PMid:18432600 6. Ong CYT, Liao AW, Spencer K, Munim S, Nicolaides KH. First trimestermaternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 2000;107: 1265-1270.
  4. Yaron Y, Heifetz S, Ochshorn Y, Lehavi O, Orr-Urtreger A. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat Diagn 2002;22:778-782. http://dx.doi.org/10.1002/pd.407 PMid:12224070 8. Smith GCS, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia and stillbirth. J Clin Endocrinol Metab 2002;87:1762-1767.
  5. Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, et al. First trimester maternal serum PAPP-A and free beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population based screening study (The FASTER Trial). Am J Obstet Gynecol 2004;191:1446-1451. http://dx.doi.org/10.1016/j.ajog.2004.06.052 PMid:15507981 10. Pilalis A, Souka AP, Antsaklis P, Daskalakis G, Papantoniou N, Mesogitis S, Antsaklis A. Screening for pre-eclampsia and fetal growth restriction by uterine